🇺🇸 FDA
Patent

US 7820182

Production of attenuated, human-bovine chimeric respiratory syncytial viruses for use in immunogenic compositions

granted A61KA61K2039/5254A61K2039/5256

Quick answer

US patent 7820182 (Production of attenuated, human-bovine chimeric respiratory syncytial viruses for use in immunogenic compositions) held by The United States of America, as represented by the Department of Health and Human Services expires Mon Oct 21 2030 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The United States of America, as represented by the Department of Health and Human Services
Grant date
Tue Oct 26 2010 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Oct 21 2030 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
11
CPC classes
A61K, A61K2039/5254, A61K2039/5256, A61K2039/543, A61K2039/544